Immunoproteins are a strong indicator for the diagnosis of diseases as they have the capacity to display characteristic serum concentration in abnormal circumstances. Immunoproteins were first used for microbial testing. The application of immunoprotein has now shifted to rapid testing. Innovative technologies have helped immunoprotein diagnostic testing systems to go beyond their traditional boundaries and enter various medical fields. Globally, the demand for various immunoproteins such as immunoglobulins, C-reactive protein (CRP), prealbumin, complement system proteins, and free light chains (FLC) of immunoglobulins.
Transparency Market Research (TMR), in a new report, states that the global immunoprotein diagnostic testing market was valued at US$11,019.7 mn in 2012 and is predicted to reach US$15,351.0 mn by 2019, expected to exhibit a 5.70% CAGR during the period between 2013 and 2019. Mergers and acquisitions of new companies are predicted to benefit the leading players operating in this global market. TMR analysts answer the following questions related to the global immunoprotein diagnostic testing market, that the key companies would like to know:
Q. How has research and development activities propelled the global immunoprotein diagnostic testing market?
Governments of many nations are increasing their funding and their support towards the research and development activities for the discovery of new ways of immunoprotein diagnostic testing. The consistently increasing research and development activities in the emerging nations have significantly contributed towards the development of the global immunoprotein diagnostic testing market. Technology has helped key companies operating in this global market to introduce new varieties of immunoprotein diagnostic testing.
Q. What are the key factors contributing towards the growth of the global demand for immunoprotein diagnostic testing?
The global immunoprotein diagnostic testing market is in its development phase and many factors have been contributing towards its growth. The need for accurate and quick disease diagnosis has increased in the emerging nations owing to the rising number of diseases. This is the primary factor expected to contribute towards the growth of the global immunoprotein diagnostic testing market. Factors such as technological advancements and a strong network of distributors in most of the emerging nations across the globe are expected to benefit the global market in the long run. The demand for preventive healthcare in developing nation is increasing, which is a vital factor expected to propel the global demand for immunoprotein diagnostic testing. Going ahead, commoditization of products will assist the key players operating in the global market in many ways.
Q. How will emerging economies contribute towards the growth of the market?
The adoption of technological advancements is increasing in all industries in emerging nations. Key companies located in emerging nations are focusing on increasing their efforts on implementing new disease diagnosis methods. The use of immunoprotein diagnostic testing methods is increasing in the emerging nations, which is a crucial factor for the growth of the global market.
Currently, immunoprotein diagnostic testing finds application in allergy testing, endocrine testing, infectious disease testing, autoimmune disease testing, toxicology testing, and oncology testing. The rising application of immunoprotein diagnostic testing is a vital factor contributing towards the growth of the global market.